Efficacy of Simvastatin Treatment of Valvular Interstitial Cells Varies With the Extracellular Environment
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Objective— The lack of therapies that inhibit valvular calcification and the conflicting outcomes of clinical studies regarding the impact of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors on valve disease highlight the need for controlled investigations to characterize the interactions between HMG-CoA reductase inhibitors and valve tissue. Thus, we applied multiple in vitro disease stimuli to valvular interstitial cell (VIC) cultures and examined the impact of simvastatin treatment on VIC function. Methods and Results— VICs were cultured on 3 different substrates that supported various levels of nodule formation. Transforming growth factor (TGF)-β1 was also applied as a disease stimulus to VICs on 2-D surfaces or encapsulated in 3-D collagen gels and combined with different temporal applications of simvastatin. Simvastatin inhibited calcific nodule formation in a dose-dependent manner on all materials, although the level of statin efficacy was highly substrate-dependent. Simvastatin treatment significantly altered nodule morphology, resulting in dramatic nodule dissipation over time, also in a substrate-dependent manner. These effects were mimicked in 3-D cultures, wherein simvastatin reversed TGF-β1–induced contraction. Decreases in nodule formation were not achieved via the HMG-CoA reductase pathway, but were correlated with decreases in ROCK activity. Conclusions— These studies represent a significant contribution to understanding how simvastatin may impact heart valve calcification.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Randomized Trial of Intensive Lipid-Lowering Therapy in Calcific Aortic Stenosis
Cowell, S. J., Newby, D. E., Prescott, R. J., Bloomfield, P., Reid, J., Northridge, D. B., & Boon, N. A. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043876 · Cited by 1,146
Effect of statins on the progression of bioprosthetic aortic valve degeneration
Antonini-Canterin, F., Zuppiroli, A., Popescu, B. A., Granata, G., Cervesato, E., Piazza, R., Pavan, D., & Nicolosi, G. L. (2003) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2003.08.066 · Cited by 81
Cited by
Rajamannan, N. M., Evans, F. J., Aikawa, E., Grande-Allen, K. J., Demer, L. L., Heistad, D. D., Simmons, C. A., Masters, K. S., Mathieu, P., O'Brien, K. D., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.006767 · Cited by 842
Self-citationJanmey, P. A., Fletcher, D. A., & Reinhart-King, C. A. (2020) · Physiological Reviews · doi:10.1152/physrev.00013.2019 · Cited by 422
Valve Interstitial Cells: The Key to Understanding the Pathophysiology of Heart Valve Calcification
Rutkovskiy, A., Malashicheva, A., Sullivan, G., Bogdanova, M., Kostareva, A., Stensløkken, K., Fiane, A., & Vaage, J. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.117.006339 · Cited by 358
Molecular Imaging Insights Into Early Inflammatory Stages of Arterial and Aortic Valve Calcification
New, S. E. P., & Aikawa, E. (2011) · Circulation Research · doi:10.1161/circresaha.110.234146 · Cited by 346
Calcification by Valve Interstitial Cells Is Regulated by the Stiffness of the Extracellular Matrix
Yip, C. Y. Y., Chen, J.-H., Zhao, R., & Simmons, C. A. (2009) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.182394 · Cited by 329
Metadata
- Authors
- Monzack, E. L., Gu, X., & Masters, K. S.
- Venue
- Arteriosclerosis, Thrombosis, and Vascular Biology
- Published
- 2009-02
- Volume
- 29
- Issue
- 2
- Pages
- 246-253
- ISSN
- 1079-5642 (ISSN-L)
- 1524-4636
- OpenAlex
- W2048036671
- Cited by
- 51
- References
- 2
- FWCI
- 4.40
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.